Injection/Infusion
PHESGO SOLUTION FOR SUBCUTANEOUS INJECTION 600MG/600MG IN 10ML
Summary
PHESGO SOLUTION FOR SUBCUTANEOUS INJECTION 600MG/600MG IN 10ML — Injection/Infusion containing pertuzumab, trastuzumab. Hong Kong Registration No. HK-67119. Certificate Holder: ROCHE HONG KONG LIMITED. Date of Registration: 25 Jun, 2021.
Product NamePHESGO SOLUTION FOR SUBCUTANEOUS INJECTION 600MG/600MG IN 10ML
Registration No.HK-67119
Certificate HolderROCHE HONG KONG LIMITED
Holder AddressUNIT 1-2, 24/F, CENTRAL PLAZA, 18, HARBOUR ROAD, WAN CHAI, HONG KONG
Ingredientspertuzumab, trastuzumab
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration25 Jun, 2021
ATC codesL01FD01, L01FD02
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents
All ATC groupsL01
This product contains more than one active ingredient. The ATC groups above describe the ingredients, not a single category for the product as a whole.
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。